Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Cepheid agrees group purchasing contract with Novation

Cepheid : 21 May, 2008  (Company News)
Cepheid has signed a contract with Novation, the industry's leading contracting services company serving VHA, University HealthSystem Consortium (UHC) and Provista.
Through its affiliations, Novation represents 49 percent of admissions, 52 percent of total surgeries and 44 percent of staffed beds in the USA. Under the terms of the contract, VHA, UHC and Provista members can take advantage of Cepheid's GeneXpert System and Xpert MRSA tests at pre-negotiated prices.

'Institutions accessing Novation contracts are recognizing that active surveillance, with rapid turnaround time, is a key component of a comprehensive Infection control programme,' said Rob Koska, Cepheid's senior vice president of worldwide commercial operations. 'We look forward to working with these institutions as they deploy the most rapid and effective surveillance testing technology in the industry.'

Xpert MRSA test results are currently available in approximately 70 minutes, thereby enabling rapid identification of carriers of the pathogen in less than two hours from the time of patient sampling to the delivery of test results to the floor. The availability of the Xpert MRSA test and the GeneXpert System is expected to enable Novation hospitals to implement more efficient Infection control measures, leading to lower HAI rates and improved patient care.

On-demand Xpert MRSA results enable healthcare professionals to rapidly identify MRSA colonized patients entering the hospital population, thereby reducing risk of potential transmission. As recent studies published in both the Journal of the American Medical Association and the Annals of Internal Medicine demonstrate, true rapid test turnaround time is critical to reaching optimal results with a fully implemented Infection control plan to reduce HAI rates and improve patient care.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo